SHPMY OTC
Shanghai Pharmaceuticals Holding Co., Ltd
1W: +10.4%
1M: -2.2%
3M: +0.0%
YTD: -14.0%
1Y: -14.7%
3Y: -7.0%
5Y: -22.5%
$7.08
+0.67 (+10.42%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$5.8B
+11.4% ▲
5Y CAGR: -0.7%
Capital Expenditures
$2.4B
+19.2% ▲
5Y CAGR: -2.7%
Free Cash Flow
$3.4B
+51.5% ▲
5Y CAGR: +0.9%
Dividends Paid
$3.6B
+9.5% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$4.4B
+47.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $5.6B | $6.3B | $7.0B | $3.8B | $5.9B |
| Depreciation & Amort. | $2.1B | $2.1B | $2.2B | $2.2B | $2.4B |
| Stock-Based Comp. | $35M | $31M | $22M | $5M | $0 |
| Change in Working Capital | -$2.0B | -$3.4B | -$4.7B | -$8.7B | -$4.3B |
| Other Non-Cash Items | $1.3B | -$151M | $319M | $8.2B | $1.9B |
| Operating Cash Flow | $6.8B | $5.1B | $4.7B | $5.2B | $5.8B |
| — Investing Activities — | |||||
| Capital Expenditures | -$3.0B | -$4.1B | -$2.7B | -$3.0B | -$2.4B |
| Acquisitions (Net) | -$2.0B | -$1.0B | $22M | -$970K | -$85M |
| Investment Purchases | -$4.5B | -$3.1B | -$39.7B | -$27.4B | -$45.9B |
| Investment Sales | $4.8B | $3.3B | $30.3B | $27.9B | $49.2B |
| Other Investing | $3.0B | -$998M | -$394M | -$5M | -$320M |
| Investing Cash Flow | -$1.7B | -$6.0B | -$12.5B | -$2.5B | $416M |
| — Financing Activities — | |||||
| Net Debt Issuance | $959M | $3.5B | $3.8B | $6.1B | $3.8B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$1.3B | -$1.4B | -$1.6B | -$4.0B | -$3.6B |
| Other Financing | -$969M | -$613M | $11.4B | -$1.9B | -$2.1B |
| Financing Cash Flow | -$1.3B | $1.6B | $12.1B | $232M | -$1.9B |
| Net Change in Cash | $3.9B | $561M | $4.4B | $3.0B | $4.4B |
| Cash End of Period | $19.6B | $20.1B | $24.5B | $27.5B | $31.9B |
| Free Cash Flow | $3.8B | $943M | $2.1B | $2.3B | $3.4B |